{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:52Z","timestamp":1781647072368,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Peripheral neuropathies and other disorders of the peripheral nervous system carry a higher mortality risk due to respiratory failure, autonomic instability, and infections. The prevalence increases with age and due to other comorbid conditions. This study evaluates mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States from 1999 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analyzed publicly available data from the CDC WONDER database (1999 to 2023) using ICD-10 codes for polyneuropathy and other disorders of the peripheral nervous system (G60-G64). Join point regression was used to compute annual percent changes and 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>70,080 deaths were reported among individuals aged\u2009\u2265\u200955 years. Most deaths occurred at decedents\u2019 homes (33.0%). AAMR increased from 3.18 in 1999 to 4.96 in 2023 (AAPC: 2.31%; 95% CI: 1.89\u20132.74%). Males maintained consistently higher AAMR than females. The greatest average CMR was demonstrated by those aged 76\u201385\u2009+\u2009years (average CMR: 8.79 per 100,000 over the study period). Most deaths were observed in NH White individuals (88.5%), while Hispanic or Latino individuals had the lowest deaths (3.90%). The West exhibited the highest AAMR (4.20), and the lowest was observed in the Northeast (2.63). Substantial disparities were observed between metropolitan and non-metropolitan areas and across various states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Polyneuropathy related mortality has demonstrated an upward trend among adults aged\u2009\u2265\u200955 years from 1999 to 2023. significant inconsistencies persist with higher mortality among older adults, males, non-Hispanic white individuals, with regional disparities favoring west. This highlights the necessity of focused public health initiatives and enhanced care accessibility for all populations and areas that are at risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-04874-w","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T02:44:51Z","timestamp":1775529891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["National mortality trends in polyneuropathies and other disorders of the peripheral nervous system in the United States, 1999\u20132023: a CDC WONDER database analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Palwasha","family":"Asghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razeena","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiullah","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arooj Ihsan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Lodh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8208-0689","authenticated-orcid":false,"given":"Kamil Ahmad","family":"Kamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"9427","key":"4874_CR1","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/S0140-6736(04)16508-2","volume":"363","author":"JD England","year":"2004","unstructured":"England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004;363(9427):2151\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(04)16508-2.","journal-title":"Lancet"},{"issue":"10","key":"4874_CR2","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285\u201393. https:\/\/doi.org\/10.2337\/dc10-1303.","journal-title":"Diabetes Care"},{"issue":"9","key":"4874_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","volume":"86","author":"EK Mathey","year":"2015","unstructured":"Mathey EK, Park SB, Hughes RAC, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015;86(9):973\u201385. https:\/\/doi.org\/10.1136\/jnnp-2014-309697.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4874_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"Global","year":"2024","unstructured":"Global. regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4):344\u201381. https:\/\/doi.org\/10.1016\/S1474-4422(24)00038-3.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4874_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barr\u00e9 syndrome. J Neurol Neurosurg Psychiatry. 2012;83(7):711\u20138. https:\/\/doi.org\/10.1136\/jnnp-2011-301882.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"4874_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(12)70065-0.","journal-title":"Lancet Neurol"},{"key":"4874_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802973-2.00015-X","volume":"138","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016;138:263\u201382. https:\/\/doi.org\/10.1016\/B978-0-12-802973-2.00015-X.","journal-title":"Handb Clin Neurol"},{"issue":"8","key":"4874_CR8","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2337\/dc23-0079","volume":"46","author":"FPB Kristensen","year":"2023","unstructured":"Kristensen FPB, Christensen DH, Callaghan BC, et al. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of \u03b2-Cell Function and Insulin Sensitivity. Diabetes Care. 2023;46(8):1546\u201355. https:\/\/doi.org\/10.2337\/dc23-0079.","journal-title":"Diabetes Care"},{"issue":"10","key":"4874_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019;19(10):86. https:\/\/doi.org\/10.1007\/s11892-019-1212-8.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"4874_CR10","doi-asserted-by":"publisher","first-page":"19159","DOI":"10.1038\/s41598-021-98565-w","volume":"11","author":"CW Hicks","year":"2021","unstructured":"Hicks CW, Wang D, Windham BG, Matsushita K, Selvin E. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep. 2021;11(1):19159. https:\/\/doi.org\/10.1038\/s41598-021-98565-w.","journal-title":"Sci Rep"},{"issue":"1","key":"4874_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5\u201320. https:\/\/doi.org\/10.1007\/s10654-015-0094-6.","journal-title":"Eur J Epidemiol"},{"key":"4874_CR12","unstructured":"National Cancer Institute. Joinpoint Regression Program. Version 5.4.0. Bethesda, MD: Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute. 2024. Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"issue":"1","key":"4874_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne D, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. https:\/\/doi.org\/10.1038\/s41572-019-0094-0. https:\/\/www.nature.com\/articles\/s41572-019-0092-1.","journal-title":"Nat Rev Dis Primers"},{"key":"4874_CR14","unstructured":"ONS. Cause of death coding in mortality statistics, software changes. Office for National Statistics; 2020. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/articles\/causeofdeathcodinginmortalitystatisticssoftwarechanges\/january2020."},{"issue":"1","key":"4874_CR15","first-page":"49","volume":"22","author":"VL Feigin","year":"2023","unstructured":"Feigin VL, et al. Global burden of neurological disorders 1990\u20132019. Lancet Neurol. 2023;22(1):49\u201364. https:\/\/pubmed.ncbi.nlm.nih.gov\/31813850\/.","journal-title":"Lancet Neurol"},{"issue":"6","key":"4874_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/jamaneurol.2022.0565","volume":"79","author":"MA Elafros","year":"2022","unstructured":"Elafros MA, Kvalsund MP, Callaghan BC. The Global Burden of Polyneuropathy\u2014In Need of an Accurate Assessment. JAMA Neurol. 2022;79(6):537\u20138. https:\/\/doi.org\/10.1001\/jamaneurol.2022.0565. https:\/\/jamanetwork.com\/journals\/jamaneurology\/article-abstract\/2790733.","journal-title":"JAMA Neurol"},{"issue":"12","key":"4874_CR17","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s00415-018-9123-1","volume":"266","author":"P Zis","year":"2019","unstructured":"Zis P, Syeed R, Glasgow N, Julian T. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol. 2019;266(12):2907\u201319. https:\/\/doi.org\/10.1007\/s00415-018-9123-1. https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9123-1.","journal-title":"J Neurol"},{"key":"4874_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12905-023-02319-x","volume":"23","author":"SM Temkin","year":"2023","unstructured":"Temkin SM, Barr E, Moore H, Caviston JP, Regensteiner JG, Clayton JA. Chronic conditions in women: the development of a National Institutes of Health framework. BMC Womens Health. 2023;23:162. https:\/\/doi.org\/10.1186\/s12905-023-02319-x. https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02319-x.","journal-title":"BMC Womens Health"},{"issue":"1\u20132","key":"4874_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10863-014-9583-7","volume":"47","author":"TG Demarest","year":"2015","unstructured":"Demarest TG, McCarthy MM. Sex differences in mitochondrial (dys)function: implications for neuroprotection. J Bioenerg Biomembr. 2015;47(1\u20132):173\u201388. https:\/\/doi.org\/10.1007\/s10863-014-9583-7. PMCID: PMC4988325. PMID:. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4988325\/.","journal-title":"J Bioenerg Biomembr"},{"key":"4874_CR20","doi-asserted-by":"crossref","unstructured":"Horvath R, Medina J, Reilly MM, Shy ME, Z\u00fcchner S. Peripheral neuropathy in mitochondrial disease. Mitochondrial Medicine: A Clinical Guide to Mitochondrial Diseases. 2nd ed. Elsevier; 2023: 283\u201398. https:\/\/doi.org\/10.1016\/B978-0-12-821751-1.00014-2. https:\/\/pubmed.ncbi.nlm.nih.gov\/36813324\/.","DOI":"10.1016\/B978-0-12-821751-1.00014-2"},{"issue":"3","key":"4874_CR21","doi-asserted-by":"publisher","first-page":"e70129","DOI":"10.1111\/ejn.70129","volume":"61","author":"Y Zhuo","year":"2025","unstructured":"Zhuo Y, Xu Y, Qu X, Li Q, Sun M, Gao X, Yuan F, Cao M, Pan B. Research on peripheral nerve aging and degeneration: Cellular changes and mechanism exploration from the perspective of single-cell sequencing. Eur J Neurosci. 2025;61(3):e70129. https:\/\/doi.org\/10.1111\/ejn.70129. https:\/\/pubmed.ncbi.nlm.nih.gov\/40317786\/.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"4874_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"MR Jones","year":"2020","unstructured":"Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, Williamson A, Viswanath O. Drug-induced peripheral neuropathy: a narrative review. Pain Ther. 2020;9(1):41\u201356. https:\/\/doi.org\/10.2174\/1574884714666190121154813. https:\/\/pubmed.ncbi.nlm.nih.gov\/30666914\/. PMCID: PMC7365998.","journal-title":"Pain Ther"},{"issue":"1","key":"4874_CR23","first-page":"38","volume":"15","author":"MR Jones","year":"2020","unstructured":"Jones MR, Urits I, Wolf J, Corrigan D, Colburn L, Peterson E, Williamson A, Viswanath O. Drug-induced peripheral neuropathy: a narrative review. Curr Clin Pharmacol. 2020;15(1):38\u201348. https:\/\/doi.org\/10.2174\/1574884714666190121144516. PMID: 30666914; PMCID: PMC7365998. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7365998\/.","journal-title":"Curr Clin Pharmacol"},{"issue":"2","key":"4874_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2020.24865","volume":"325","author":"SH Woolf","year":"2021","unstructured":"Woolf SH, Chapman DA, Lee JH. COVID-19 is the leading cause of death in the United States. JAMA. 2021;325(2):123\u20134. https:\/\/doi.org\/10.1001\/jama.2020.24865. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2774465.","journal-title":"JAMA"},{"issue":"12","key":"4874_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","volume":"78","author":"L Amezcua","year":"2021","unstructured":"Amezcua L, Rivera VM, Corona V\u00e1zquez T, et al. Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review. JAMA Neurol. 2021;78(12):1515\u201324. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3538. https:\/\/jamanetwork.com\/journals\/jamaneurology\/article-abstract\/2784442.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4874_CR26","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1212\/WNL.0000000000207916","volume":"102","author":"MP McGinley","year":"2024","unstructured":"McGinley MP, Harvey T, Lopez R, Ontaneda D, Buchalter RB. Geographic disparities in access to neurologists and multiple sclerosis care in the United States. Neurology. 2024;102(2):e97\u2013107. https:\/\/doi.org\/10.1212\/WNL.0000000000207916. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11407503\/.","journal-title":"Neurology"},{"issue":"24","key":"4874_CR27","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1212\/WNL.0000000000004025","volume":"88","author":"A Saadi","year":"2017","unstructured":"Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology. 2017;88(24):2268\u201375. https:\/\/doi.org\/10.1212\/WNL.0000000000004025. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5567325\/.","journal-title":"Neurology"},{"issue":"26","key":"4874_CR28","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","volume":"382","author":"EG Price-Haywood","year":"2020","unstructured":"Price-Haywood EG, et al. Hospitalization and mortality among Black and White patients with COVID-19. NEJM. 2020;382(26):2534\u201343. https:\/\/pubmed.ncbi.nlm.nih.gov\/32459916\/.","journal-title":"NEJM"},{"key":"4874_CR29","doi-asserted-by":"publisher","first-page":"E088","DOI":"10.5888\/pcd13.160088","volume":"13","author":"KM Shaw","year":"2016","unstructured":"Shaw KM, Theis KA, Self-Brown S, Roblin DW, Barker L. Chronic disease disparities by county economic status and metropolitan classification, Behavioral Risk Factor Surveillance System, 2013. Prev Chronic Dis. 2016;13:E088. https:\/\/doi.org\/10.5888\/pcd13.160088. https:\/\/www.cdc.gov\/pcd\/issues\/2016\/16_0088.htm.","journal-title":"Prev Chronic Dis"},{"issue":"22","key":"4874_CR30","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1001\/jama.2021.5334","volume":"325","author":"SH Cross","year":"2021","unstructured":"Cross SH, Califf RM, Warraich HJ. Rural\u2013urban disparity in mortality in the US from 1999 to 2019. JAMA. 2021;325(22):2312\u20134. https:\/\/doi.org\/10.1001\/jama.2021. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8188271\/.","journal-title":"JAMA"},{"key":"4874_CR31","doi-asserted-by":"crossref","unstructured":"Ganapathy K. Telemedicine and neurological practice in the COVID-19 era. Neurol India. 2020;68(5):1042\u20131049. https:\/\/doi.org\/10.4103\/0028-3886.288994. PMID: 32643663. https:\/\/pubmed.ncbi.nlm.nih.gov\/32643663\/","DOI":"10.4103\/0028-3886.288994"},{"issue":"2","key":"4874_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/diagnostics11020165","volume":"11","author":"J Burgess","year":"2021","unstructured":"Burgess J, Frank B, Marshall A, Khalil RS, Ponirakis G, Petropoulos IN, Cuthbertson DJ, Malik RA, Alam U. Early detection of diabetic peripheral neuropathy: a focus on small nerve fibres. Diagnostics (Basel). 2021;11(2):165. https:\/\/doi.org\/10.3390\/diagnostics11020165. PMID: 33498918; PMCID: PMC7911433. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7911433\/.","journal-title":"Diagnostics (Basel)"},{"key":"4874_CR33","unstructured":"Fornari A, Lanza M, Guastafierro E, Marcassoli A, Sismondo P, Curatoli C, Raggi A, Leonardi M. Inequities in neurological care: Access to services, care gaps, and other barriers\u2014A systematic review. Front Neurol. 2024;15:1388891. https:\/\/doi.org\/10.3389\/fneur.2024.1388891. PMID: 39582360; PMCID: PMC11625953. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11625953\/"},{"issue":"5","key":"4874_CR34","first-page":"973","volume":"62","author":"SH Cross","year":"2021","unstructured":"Cross SH, Warraich HJ. Changes in place of death in the United States. J Pain Symptom Manage. 2021;62(5):973\u201381. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.08.040. https:\/\/www.jpsmjournal.com\/article\/S0885-3924(20)30258-X\/fulltext?utm_source=chatgpt.com.","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"4874_CR35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"Global Burden of Disease Study 2016","year":"2019","unstructured":"Global Burden of Disease Study 2016. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the. Lancet Neurol. 2019;18(5):459\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6459001\/.","journal-title":"Lancet Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04874-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04874-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04874-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:33:38Z","timestamp":1781645618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04874-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4874"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04874-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified data from CDC WONDER and was exempt from institutional review board approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}